CytomX Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

사이톰엑스 테라퓨틱스NASDAQ:CTMX · Nasdaq · Healthcare

$2.56-2.66%

2026-10-02 close

CytomX Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $138M. 2024 operating profit was $25M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy